Matches in Wikidata for { <http://www.wikidata.org/entity/Q37663361> ?p ?o ?g. }
- Q37663361 description "article científic" @default.
- Q37663361 description "article scientifique" @default.
- Q37663361 description "articolo scientifico" @default.
- Q37663361 description "artigo científico" @default.
- Q37663361 description "artículu científicu espublizáu en 2014" @default.
- Q37663361 description "bilimsel makale" @default.
- Q37663361 description "scientific article published on 07 February 2014" @default.
- Q37663361 description "vedecký článok" @default.
- Q37663361 description "vetenskaplig artikel" @default.
- Q37663361 description "videnskabelig artikel" @default.
- Q37663361 description "vědecký článek" @default.
- Q37663361 description "wetenschappelijk artikel" @default.
- Q37663361 description "wissenschaftlicher Artikel" @default.
- Q37663361 description "наукова стаття, опублікована в лютому 2014" @default.
- Q37663361 description "научни чланак" @default.
- Q37663361 description "مقالة علمية نشرت في 07 فبراير 2014" @default.
- Q37663361 name "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 name "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 name "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 type Item @default.
- Q37663361 label "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 label "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 label "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 prefLabel "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 prefLabel "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 prefLabel "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial." @default.
- Q37663361 P1433 Q37663361-9439ACF2-C8FF-4E95-B8EA-5FB601B9BB0F @default.
- Q37663361 P1476 Q37663361-0BC6116C-0F30-45F6-9AA9-A2CD58E4E467 @default.
- Q37663361 P2093 Q37663361-194E8C87-7939-4DE0-AD73-5A220BB27348 @default.
- Q37663361 P2093 Q37663361-1D989B5A-1262-496C-A3D4-756B4357302C @default.
- Q37663361 P2093 Q37663361-56DDED8F-FB12-431F-8CDF-F82AA5D9B603 @default.
- Q37663361 P2093 Q37663361-92129E89-C0FA-40A2-98B6-F04780AB8983 @default.
- Q37663361 P2093 Q37663361-BCDFB1DB-7D56-40DB-8F50-62112AB8C6CB @default.
- Q37663361 P2093 Q37663361-F9E31931-FD3F-4171-9BEF-F0A5F64A49D0 @default.
- Q37663361 P2860 Q37663361-13F7F7FD-02CB-44C9-8E3E-7E69EB069E72 @default.
- Q37663361 P2860 Q37663361-3361A92A-C93E-442B-9CEF-A99CD95AD173 @default.
- Q37663361 P2860 Q37663361-40A12042-B197-4F71-8D8B-FFF0323719DB @default.
- Q37663361 P2860 Q37663361-48FF6D01-23CC-423A-8F5A-6A7A1FD9B86C @default.
- Q37663361 P2860 Q37663361-621046E2-BBBE-42AD-96AA-EE640DD84D8D @default.
- Q37663361 P2860 Q37663361-6B5AFFA3-C147-4123-B048-C1E08BB62502 @default.
- Q37663361 P2860 Q37663361-770B8E4D-E5A4-4C92-AB22-0FC017A8F6DB @default.
- Q37663361 P2860 Q37663361-8D450A3A-EFD7-4C04-8812-49CF34CF1D45 @default.
- Q37663361 P2860 Q37663361-9703332B-3CB6-414D-A019-FE727C04ABCB @default.
- Q37663361 P2860 Q37663361-A098867D-094D-4636-B89E-AD14AA86C384 @default.
- Q37663361 P2860 Q37663361-B3C965E9-75AA-4DDB-8A82-4622907152C0 @default.
- Q37663361 P2860 Q37663361-BBE8EA66-C18B-462C-8889-E8510A441989 @default.
- Q37663361 P2860 Q37663361-CFDE70E9-36D5-4FC3-AB68-0CDF5D55A99B @default.
- Q37663361 P2860 Q37663361-E5CBD0C3-94F3-4392-8274-25DB6B9D5F36 @default.
- Q37663361 P2860 Q37663361-E854B4FC-0F0E-48F4-97FF-5043DAD2BF5C @default.
- Q37663361 P2860 Q37663361-FC813C49-1068-42BB-98E4-1E269FC154E8 @default.
- Q37663361 P2860 Q37663361-FC914377-3580-4019-B2F2-3502B6AB003D @default.
- Q37663361 P304 Q37663361-80413ABB-D5F3-452E-AE24-4ECDFDE8B323 @default.
- Q37663361 P31 Q37663361-F6F107B5-7B8D-4C0C-92E8-872684B6115F @default.
- Q37663361 P356 Q37663361-E575C482-CEEB-48B3-8211-7C556105FC01 @default.
- Q37663361 P433 Q37663361-64A80CED-E824-4F3D-A7CF-550549956912 @default.
- Q37663361 P478 Q37663361-93FF6BCE-A7A6-4061-90E3-82DF6D312222 @default.
- Q37663361 P50 Q37663361-3B88E14C-0919-4ED5-A1B5-85A53F33EC3A @default.
- Q37663361 P577 Q37663361-4EBA1C06-1297-4638-B007-D5DC4F07CC8D @default.
- Q37663361 P5875 Q37663361-C6433C4C-2A05-4F63-B22F-DF9BBC7DC537 @default.
- Q37663361 P698 Q37663361-50B78AA2-CDB9-4E73-80DF-A548957B1BF0 @default.
- Q37663361 P921 Q37663361-5B89B29E-0B4C-43FD-81AC-5798A6ACE9C5 @default.
- Q37663361 P921 Q37663361-773FAFC7-F5AC-4B61-A133-A811B7A992E5 @default.
- Q37663361 P932 Q37663361-D7904BFC-B361-4E53-B9A2-A9D9E1C7A518 @default.
- Q37663361 P356 IRCMJ.15277 @default.
- Q37663361 P698 24719748 @default.
- Q37663361 P1433 Q26842886 @default.
- Q37663361 P1476 "Evaluation of Aggregometery Parameters and Efficacy of Plavix versus Clopidex in Patients Suffering from Ischemic Heart Disease: A Randomized Double Blind Clinical Trial" @default.
- Q37663361 P2093 "Bita Najafian" @default.
- Q37663361 P2093 "Davoud Kazemisaleh" @default.
- Q37663361 P2093 "Majid Shohrati" @default.
- Q37663361 P2093 "Maryam Moshkani" @default.
- Q37663361 P2093 "Minoo Ahmadinejad" @default.
- Q37663361 P2093 "Nastaran Najafian" @default.
- Q37663361 P2860 Q28165115 @default.
- Q37663361 P2860 Q28191552 @default.
- Q37663361 P2860 Q28200575 @default.
- Q37663361 P2860 Q28212867 @default.
- Q37663361 P2860 Q29620666 @default.
- Q37663361 P2860 Q33504515 @default.
- Q37663361 P2860 Q33699761 @default.
- Q37663361 P2860 Q34021353 @default.
- Q37663361 P2860 Q34651818 @default.
- Q37663361 P2860 Q34963382 @default.
- Q37663361 P2860 Q36574499 @default.
- Q37663361 P2860 Q37198893 @default.
- Q37663361 P2860 Q45796603 @default.
- Q37663361 P2860 Q45950570 @default.
- Q37663361 P2860 Q46213517 @default.
- Q37663361 P2860 Q46835667 @default.
- Q37663361 P2860 Q77684472 @default.
- Q37663361 P304 "e15277" @default.
- Q37663361 P31 Q13442814 @default.
- Q37663361 P356 "10.5812/IRCMJ.15277" @default.
- Q37663361 P433 "2" @default.
- Q37663361 P478 "16" @default.
- Q37663361 P50 Q83611900 @default.
- Q37663361 P577 "2014-02-07T00:00:00Z" @default.
- Q37663361 P5875 "261521613" @default.
- Q37663361 P698 "24719748" @default.
- Q37663361 P921 Q29006343 @default.